Comparing Two Therapies to Improve Arm Function After Stroke
Launched by UNIVERSITY OF LAHORE · Jul 22, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different therapy approaches to help improve arm and hand function in people who have weakness after a stroke. The goal is to see which therapy—either constraint-induced movement therapy (CIMT), where the stronger arm is gently restricted to encourage use of the weaker arm, or coupling rehabilitation combined with regular physical therapy—works better to restore movement and help with daily activities like eating or dressing. Participants will receive 12 weeks of therapy and will be tested before, during, and after the treatment to measure their progress.
People who might be eligible for this study are adults between 40 and 65 years old who have had a stroke recently and experience moderate arm weakness. To join, participants need to have certain levels of arm movement and hand skills based on specific tests, and they should not have serious heart problems, organ failure, recent injuries to their arms, or memory and thinking problems unrelated to the stroke. If accepted, participants can expect to be randomly assigned to one of the two therapies and attend regular sessions for 3 months. The results of this study may help improve rehabilitation methods for stroke survivors in the future.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: •Age 40-65 years old
- • Patients suffering from Sub acute stroke
- • Motor function score at Fugl-Meyer Assessment between 40-60
- • Fine motor assessment at Box and Block Test\<20
- * ADL's assessment at Motor Activity Log:
- • Amount of use scale\<2.5 Quality of movement scale\<3
- • -
- Exclusion Criteria:
- • Individuals suffering from unstable angina, symptomatic heart failure, or uncontrolled hypertension
- • Physician determined unstable cardiovascular conditions
- • The patient has been diagnosed as having organ failure, including the heart, kidneys, and lungs
- • Patients with any traumatic musculoskeletal injury to upper limbs
- • Individuals who are experiencing cognitive impairment as a result of neurological conditions other than stroke.
About University Of Lahore
The University of Lahore is a leading academic institution dedicated to advancing healthcare research and education. With a robust commitment to scientific inquiry, the university sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging its state-of-the-art facilities and interdisciplinary expertise, the University of Lahore collaborates with healthcare professionals and researchers to conduct innovative studies that address pressing health challenges. Through its clinical trial initiatives, the university strives to contribute to evidence-based practices and foster advancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Maryam Shabbir, PH.D. PT
Principal Investigator
The University of Lahore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported